ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (D... ( ADDISON Texas March 18 /- ULURU Inc. ...)

HOME >> MEDICINE >> TECHNOLOGY

ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009

Date:3/18/2009

ADDISON, Texas, March 18 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced that clinical evidence on the treatment of diabetic foot ulcers, and data on the use of its patented Nanoflex(TM) Technology for Therapeutic Delivery will be presented at the annual DFCon Global Meeting in Los Angeles, California March 19-21. The work will be presented on posters that will be on display during the meeting.

Clinical evidence will be presented on a poster titled, "Nanoparticulate Aggregate Wound Dressing in the Management of Soft Tissue Wounds". This research details the application of Altrazeal(TM) in the treatment of a patient following radical debridement of necrotizing fasciitis. Commenting on the work, DFCon organizer and one of the study's co-authors, Dr. David Armstrong, Professor of Surgery and Director, Southern Arizona Limb Salvage Alliance (SALSA) University of Arizona College of Medicine stated, "We have been provisionally impressed with this modality. We believe that marrying such technologies with an aggressive team effort might well prove helpful in reducing the unnecessarily high rate of amputations in the USA and worldwide."

Further clinical evidence for the use of Altrazeal(TM) in treating diabetic foot ulcers is detailed in a poster titled "Properties of a Novel Powder Wound Dressing and Clinical Experience in Diabetic Foot Ulcers." This work presents the use of Altrazeal(TM) Transforming Powder Dressing in the treatment of four separate ulcers in diabetic patients. The treatments were performed by Gregory Bohn, MD FACS, the Medical Director of Trinity Center for Wound Care and Hyperbaric Medicine in Bettendorf, IA., Sid Sharma, DPM FAPWCA, and Gianni Persich, DPM FAPWCA both at All Country Podiatry in NY. Four cases of ulcers present on heel, to
'/>"/>

SOURCE ULURU Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
3. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
4. Quark Pharmaceuticals Presents at Asia TIDES Conference
5. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
6. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
7. Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma
8. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
9. Spectral presents data on the clinical utility of EAA(TM) at 13th Annual Critical Care for Endotoxemia conference in Japan
10. Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009
11. Atritech to Participate in Late-Breaking Clinical Trial Presentation at American College of Cardiology Meeting

Post Your Comments:

(Date:6/18/2013)... New-generation electronic designs are focused on ... Simultaneously, circuitry is increasing the number of functions ... it performs at. Connecting cables from the active ... such as cameras or detectors, must be small, ... include custom cable designs for high-quality signal and ...

(Date:6/18/2013)... Apama Medical, a privately held medical ... atrial fibrillation technologies, today announced the issuance of ... and Trademark Office (USPTO), titled "Low Profile Electrodes". ... use on expandable structures such as balloons used ... "We are grateful to the NSF SBIR ...

(Date:6/17/2013)... 2013 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... at ENDO 2013, the Endocrine Society,s 95 th ... (synchronize) both melatonin and cortisol rhythms. This effect ... body clock and address the circadian desynchrony which ... (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal ...

Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4

[0] Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility [0] Apama Medical Announces Issuance Of Patent For Low Profile Electrodes For Use On Balloons [0] Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder

... Inc . announced today that David A. Weber, Ph.D. , ... Board of Directors. Jay Lichter, Ph.D., managing director of Avalon Ventures, ... actively support the company as a member of the Board of ... to the Otonomy team, as his extensive experience in the development ...

... 2010 Amicus Therapeutics (Nasdaq: FOLD ), ... diseases, today announced that it has been awarded a ... Parkinson,s Research (MJFF) for the development of a novel, ... The $500,000 award will be distributed over a period ...

Cached Medicine Technology:Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer 2 Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer 3 Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 2 Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 3 Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 4 Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 5

Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease

(Date:6/18/2013)... Palo Alto has taken yet another step ... with its recent major long-term solar power commitment. , ... electric power purchase agreements , which together will result in ... photovoltaic electric power per year, which is the equivalent of ... enough power to supply all 65,000+ Palo Alto residents---and then ...

(Date:6/18/2013)... 18, 2013 Seven-year-old Riley Salz of ... autism. He receives 40 hours a week of applied ... from the Center for Autism and Related Disorders (CARD). ... 2008, and has experienced remarkable progress, including learning to ... environment. Riley’s personal journey through autism is now featured ...

(Date:6/18/2013)... have launched an innovative clinical trial, unique in ... a patient,s own stem cells to prevent leg ... , Led by Vik Kashyap, MD, Division ... Center,s Harrington Heart & Vascular Institute and Professor ... of Medicine, the clinical trial is designed to ...

(Date:6/18/2013)... Ill. (PRWEB) June 18, 2013 More than ... are living with HIV/AIDS, according to the Centers for Disease ... know they are infected. In support of National HIV Testing ... Social Security Disability Insurance (SSDI) representation, the CDC and ... testing. , The CDC reports about 50,000 new HIV ...

(Date:6/18/2013)... 2013 myCNAjobs announces the addition of ... articles, and tips to the Caregiver Resources Center. , ... the 10,000+ retiring baby boomers each day, the need ... job resources has never been greater. myCNAjobs, ... community, recently launched the first-ever free resource center for ...

Breaking Medicine News(10 mins):Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2 Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3 Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2 Health News:Allsup Observes National HIV Testing Day June 27 2 Health News:Allsup Observes National HIV Testing Day June 27 3 Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2

[0] Palo Alto Seals the Deal on Major Solar Electric Investments [0] June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy [0] UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation [0] Allsup Observes National HIV Testing Day June 27 [0] myCNAjobs Adds New Resources to Growing Caregiver Career Center

... plans that give best value for money, study finds , ... aren,t implementing strategies and programs to improve the quality and ... in the Nov. 21 issue of the Journal of ... Health researchers surveyed 609 executives of the largest employers ...

... Inc. (TSX: DDS;,NASDAQ: DDSS) today announced that it ... and Drug Administration (FDA) regarding its appeal of ... through,the Formal Dispute Resolution process. In the response, ... II, Center for Drug Evaluation and,Research has not ...

... Sullivan,s industry research concludes, ,Masimo pulse oximetry is ... sign module clinicians ask for by brand, IRVINE, ... Pulse CO-Oximetry and Read-Through Motion and Low,Perfusion pulse oximetry, ... Best Practices Award, for Pulse Oximetry Leadership -- "ranking,number ...

... 20 NNN Healthcare/Office REIT,Inc. has acquired ... 15, 2007. Northmeadow Medical Center is ... the Atlanta suburb of Roswell,Georgia. Built in ... is,strategically located directly across the street from ...

... 20 CHF,International has been selected as the ... Fund) new Principal Recipient (PR) for,HIV/AIDS prevention, treatment ... awarded an HIV proposal in Round 3 programming., ... years, CHF will be directly responsible for,managing Honduras, ...

... Ga., Nov. 20 Immucor, Inc. (Nasdaq:,BLUD), a ... blood transfusion industry, announced today that Richard A. ... and Chief Financial Officer,effective December 10, 2007. The ... to resign for family reasons but had agreed ...

Cached Medicine News:Health News:Most U.S. Companies Do Little to Boost Worker Health Benefits 2 Health News:Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol 2 Health News:Masimo Corporation Receives a Frost & Sullivan 2007 Industry Best Practices Award for Pulse Oximetry Leadership 2 Health News:Masimo Corporation Receives a Frost & Sullivan 2007 Industry Best Practices Award for Pulse Oximetry Leadership 3 Health News:Masimo Corporation Receives a Frost & Sullivan 2007 Industry Best Practices Award for Pulse Oximetry Leadership 4 Health News:NNN Healthcare/Office REIT Acquires Northmeadow Medical Center in Roswell, Georgia 2 Health News:NNN Healthcare/Office REIT Acquires Northmeadow Medical Center in Roswell, Georgia 3 Health News:CHF International Named Global Fund Principal Recipient in Honduras 2 Health News:Immucor, Inc. Appoints New Chief Financial Officer 2

Most U.S. Companies Do Little to Boost Worker Health Benefits Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol Masimo Corporation Receives a Frost & Sullivan 2007 Industry Best Practices Award for Pulse Oximetry Leadership NNN Healthcare/Office REIT Acquires Northmeadow Medical Center in Roswell, Georgia CHF International Named Global Fund Principal Recipient in Honduras Immucor, Inc. Appoints New Chief Financial Officer

Eyeglass Loupe 3x-5x made with precision optical glass. Ideal for any detail work....

Includes near contrast sensitivity card, calibrated holder, light meter, answer key and instruction manual contrast vision test developed by Arthur P. Ginsburg, Ph.D....

Near PT test card/4 1/2 to 12 PT in spanish & french /5 1/2" X 8....

Card has Jaeger rating and snellen equivalent....

Medicine Products:

Classic Metal Eyeglass Loupes Near Functional Acuity - Fact101 Near PT Test Card/4 1/2 to 12 - BC2205 AOA Near PT Acuity Card - BCAOA